Table 1. Efficacy endpoints.
Parameter | Baseline | Immediately after treatment | Six months |
Investigator-reported LFS2 | 1.9 ± 0.9 | 2.5 ± 0.9* | 2.4 ± 1.0*,§ |
Investigator-reported GAIS | N/A | 2.9 ± 0.9 | 2.9 ± 0.7§ |
Subject-reported GAIS | N/A | 3.0 ± 0.9 | 3.0 ± 0.8§ |
Subject-reported assessment of the natural look and feel of lips | N/A | 3.8 ± 0.6 | 3.7 ± 0.9§ |
Subject-reported HMS | 7.4 ± 1.8 | 9.3 ± 0.6* | 9.1 ± 0.6*,§ |